Showing results (1-10 of 411) with videos related to

Sort By:
Pageof 42
Journal of Neurochemistry|January 18, 2021
Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer's disease" on page 658Gerhard Gründer, Paul Cumming
Behavioural Brain Research|November 16, 2020
Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorderPaul Cumming, Anissa Abi-Dargham, Gerhard Gründer
Current Topics in Behavioral Neurosciences|January 13, 2023
Molecular Imaging Studies of Alcohol Use DisorderPatrick Bach, Philippe de Timary, Gerhard Gründer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 25, 2005
PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacityYoshitaka Kumakura, Ingo Vernaleken, Gerhard Gründer, et al.
Psychopharmacology|November 7, 2014
Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteersTanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, et al.
Psychopharmacology|May 3, 2018
The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophreniaTanja Veselinović, Ingo Vernaleken, Hildegard Janouschek, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|June 24, 2010
Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depressionGerhard Gründer
Pharmacopsychiatry|June 25, 2021
Psychedelics: A New Treatment Paradigm in Psychiatry?Gerhard Gründer
Human Brain Mapping|November 30, 2006
'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigationIngo Vernaleken, Hans-Georg Buchholz, Yoshitaka Kumakura, et al.
Translational Psychiatry|October 1, 2025
The sense and nonsense of antipsychotic combinations: A model for dopamine D2/3 receptor occupancyMoritz Spangemacher, Christian N Schmitz, Paul Cumming, et al.
Pageof 42